TY  - GEN
AU  - Peiró,G
AU  - Ortiz-Martínez,F
AU  - Gallardo,A
AU  - Pérez-Balaguer,A
AU  - Sánchez-Payá,J
AU  - Ponce,J J
AU  - Tibau,A
AU  - López-Vilaro,L
AU  - Escuin,D
AU  - Adrover,E
AU  - Barnadas,A
AU  - Lerma,E
TI  - Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
SN  - 1532-1827
PY  - 2014///1006
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Central Nervous System Neoplasms
KW  - Chemotherapy, Adjuvant
KW  - Class I Phosphatidylinositol 3-Kinases
KW  - DNA Mutational Analysis
KW  - Drug Resistance, Neoplasm
KW  - Enzyme Activation
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Phosphatidylinositol 3-Kinases
KW  - genetics
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Signal Transduction
KW  - Trastuzumab
KW  - src-Family Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2014.327
ER  -